This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Cytokinetics Inc (CYTK)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 20.16M 14.91M 18.83M 17.51M
Receivables 5.00K 4.00K 14.00K 46.00K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 79.34M 76.43M 51.14M 73.50M
Property, Plant & Equipment, Gross 22.21M 24.28M 24.10M 24.10M
Accumulated Depreciation & Depletion 20.99M 23.29M 22.79M 21.78M
Property, Plant & Equipment, Net 1.22M 997.00K 1.31M 2.32M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 2.63M 127.00K 323.00K 2.17M
Total Non-Current Assets 3.85M 1.12M 1.63M 4.49M
Liabilities & Shareholder Equity
Total Assets 83.19M 77.55M 52.77M 77.99M
Accounts Payable 3.71M 2.15M 1.21M 1.12M
Short Term Debt 0.00 0.00 152.00K 833.00K
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 26.70M 7.10M 4.59M 7.32M
Long Term Debt 0.00 0.00 0.00 152.00K
Deferred Income Taxes 542.00K 361.00K 3.00K 0.00
Other Non-Current Liabilities 1.50M 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 2.04M 361.00K 3.00K 152.00K
Total Liabilities 28.75M 7.47M 4.60M 7.48M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 54.44M 70.08M 48.18M 70.52M
Common Par 31.00K 143.00K 75.00K 67.00K
Additional Paid In Capital 537.00M 518.80M 456.61M 431.10M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -482.60M -448.88M -408.51M -360.65M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 7.00K 18.00K 3.00K -4.00K
Total Capitalization 54.44M 70.08M 48.18M 70.67M
Total Equity 54.44M 70.08M 48.18M 70.52M
Total Liabilities & Stock Equity 83.19M 77.55M 52.77M 77.99M
Total Common Shares Outstanding 30.68M 23.74M 12.49M 11.15M
Preferred Shares 4.00K 23.03K 8.07K 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 27.28M 18.11M 11.80M 10.69M
Diluted Weighted Shares Outstanding 27.28M 18.11M 11.80M 10.69M
Number of Employees 85 70 79 105
Number of Part-Time Employees 0 0 0 0
CYTK News

CYTK Cytokinetics Inc

Analysts Ratings for CYTK

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 1 1
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET CYTK ANALYST REPORT

Brokerage Partners

CYTK Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs